Ovarian Cancer

A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine Encoding the Amino Acids 1-163 of Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) in Patients with Advanced Ovarian Cancer (OC) Scientific Description Clinical Description

Clinical Trials Contact

For more information regarding our trials, please call our Patient Coordinator

Stephanie Parker
866-932-8588
Email